🔎 Trials Near Me

Home › Diffuse Intrinsic Pontine Glioma › Florida

Pag-aaral pangklinika para sa Diffuse Intrinsic Pontine Glioma sa Florida

7 pag-aaral para sa Diffuse Intrinsic Pontine Glioma ang naghahanap ng mga kalahok sa mga site sa Florida.

Mga Lungsod sa Florida

Opisyal na teksto ng pag-aaral (English)

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • Nicklaus Children's Hospital, Miami
Nagre-recruitPhase 2
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06838676

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • Johns Hopkins All Children's Hospital, St. Petersburg
Nagre-recruitPhase 1/2
12 Months – 21 Years · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04870944

Targeted Pediatric High-Grade Glioma Therapy

  • University of Miami, Miami
Nagre-recruitObservasyonal na pag-aaral
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • University of Florida, Gainesville
  • Nicklaus Children's Hospital, Miami
  • Arnold Palmer Hospital for Children, Orlando
  • at 1 pa
Nagre-recruitPhase 1/2
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199

Study of Olutasidenib and Temozolomide in HGG

  • University of Miami Hospital and Clinics, Miami
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Nicklaus Children's Hospital, Miami
Nagre-recruitPhase 2
Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

  • Jackson Memorial Hospital, Miami
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 8, 2025 · NCT05956821

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.